← Open Payments lookup

CHRISTOPHER DAVIS: Open Payments

NPI 1265483283 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$956 in 50 payments from 17 companies in 2025. Trend: 2023 $386 · 2024 $542 · 2025 $956

Food & beverage: $956
CompanyPaymentsAmount
ViiV Healthcare Company10$192
Gilead Sciences, Inc.7$162
Lilly USA, LLC5$88
ABBVIE INC.3$69
AstraZeneca Pharmaceuticals LP4$60
PFIZER INC.3$58
Novo Nordisk Inc3$51
Astellas Pharma US Inc2$45
Biogen, Inc.2$43
Merck Sharp & Dohme LLC2$39

Products named: DOVATO, MOUNJARO, RUKOBIA, Veozah, SKYCLARYS, PIFELTRO, ELIQUIS, MAVYRET.

Industry payments across MD — which companies pay providers there.